CDSCO monthly lab alert
CDSCO NSQ alert, December 2025: 175 drug batches flagged
By Blacklisted editorial team· Published 20 Jan 2026· Updated 20 Sep 2026· Source: CDSCO NSQ portal
In its December 2025 alert, the Central Drugs Standard Control Organisation listed 175 drug batches that failed quality tests, 71 at central laboratories and 104 at state drug-testing laboratories, from 147 manufacturers across 138 products. The most common failure was assay, and the most-represented manufacturing state was Himachal Pradesh. Products flagged include Albendazole Tablets IP 400 mg, Sorbitol Solution 70% IP (Non-Crystallizing), Piperacillin and Tazobactam Injection I.P. 4.5 gm.
175
Batches flagged
71 / 104
Central / state labs
Assay
Top reason
147
Manufacturers
Batches per month, last 12 alerts
Jan 2025Dec 2025 · 175
Full list of NSQ batches, December 2025
Download CSV| Product | Batch | Manufacturer | Reason declared NSQ | Tested by |
|---|---|---|---|---|
| Zinc Sulphate Dispersible Tablets I.P. | MT10502Mfg 2025-06 · Exp 2027-05 | McW Healthcare (P) Ltd. 286Madhya Pradesh | the sample does not conforms to claim as per IP 2022 in respect to the uniformity of Dispersion & Disintegrstion testUniformity of weight/content | DTL BaddiState lab |
| X-Plus Gold | VBX-044Mfg 2025-06 · Exp 2028-05 | Vaidban Ayurved Bhawan Vill. FadauliHaryana | The sample does not conform to claim as per Patent and Proprietary in respect to The Test of TadalafilOther | RDTL, ChandigarhCDSCO lab |
| Voglibose Tablets IP Vobil 0.2 Tables | T-2404094Mfg 2024-04 · Exp 2026-03 | Oscar House | DescriptionDescription | FDAL, MumbaiState lab |
| Vildagliptin and Metformin Tablets IP | VMHT1315Mfg 2025-05 · Exp 2027-04 | Unicure India Ltd C-21Uttar Pradesh | The sample received does not conform to I.P. 2022 with respect to Assay and Dissolution.Assay | CDTL, MumbaiCDSCO lab |
| Tigecycline Injection IP 50 mg Tigelite Injection 50mg) | LAA139Mfg 2025-03 · Exp 2027-02 | Lyka Labs Ltd. Plot No. 4801/B & 4802/AGujarat | The sample does not conform to I.P. 2022 with respect to test for Related substances .Related substances | CDTL, MumbaiCDSCO lab |
| Terbutaline Sulphate, Bromhexine Hydrochloride Guaiphenesin & Menthol Syrup(Cofflet Syrup ) | SCFL-2504Mfg 2025-10 · Exp 2027-03 | Heal (India) Laboratories Pvt Ltd | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Telmisartan Tablets IP 40mg Savtel 40 Tablets | PT- 40584Mfg 2024-02 · Exp 2026-01 | Pharmaroots Healthcare Khasra No. 411Himachal Pradesh | The sample does not comply as per I.P. 2022 with respect to The test for Dissolution of Telmisartan.Dissolution | RDTL, GuwahatiCDSCO lab |
| Telmisartan Tablets IP 40mg | 493TTF020Mfg 2025-08 · Exp 2027-07 | Swiss Garnier Life SciencesHimachal Pradesh | Sample fails the test Dissolution.Dissolution | RDTL Ernakulam,KeralaState lab |
| Telmisartan Tablets IP 40MG | TEP25123ALMfg 2025-05 · Exp 2027-04 | Hindustan Laboratories LimitedMaharashtra | The sample does not confirm to IP 2022 requirement with respect to Dissolution TestDissolution | DTL,Dalgate Srinagar Kashmir (J & K)State lab |
| Telmisartan Tablets IP 40 mg | BPLT-24205Mfg 2024-08 · Exp 2026-07 | Bennet Pharmaceuticals LtdHimachal Pradesh | Dissolution, Uniformity of content (Telmisartan)Dissolution | SDTL, GuwahatiState lab |
| Telmisartan Tablets IP | 24305Mfg 2024-10 · Exp 2026-09 | BENNET Pharmaceuticals Ltd. VILL-Chanal Majra Near-ManpuraHimachal Pradesh | The sample is not of standard quality for The reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Telmisartan Tablets I.P. 40 mg | GT-2503Mfg 2025-03 · Exp 2027-02 | Helax Healthcare Pvt. LtdUttarakhand | The sample does not conform to I.P.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab |
| TELTAN-MT 25 | 2507017Mfg 2025-07 · Exp 2027-06 | Santus Global Formulations Limited (Who-GMP Certified Company) Khasra No.587/588 Village Kunjhal Blackside JharmajriHimachal Pradesh | The sample does not conform to I.P w.r.t the test for Disintegration TestDisintegration | DTL,Dalgate Srinagar Kashmir ( J & K)State lab |
| Sorbitol Solution 70% IP (Non-Crystallizing) | KA/017Mfg 2025-08 · Exp 2030-07 | Gujarat Ambuja Exports Limited Sy No 153/1Gujarat | The sample received does not conform to I.P. 2022 specification with respect to The content of ethylene glycol impurity, which is exceeding permissible limitOther | CDTL-HyderabadCDSCO lab |
| Sorbitol Solution 70% IP (Non-Crystallizing) | KA/017Mfg 2025-08 · Exp 2030-08 | Gujarat Ambuja Exports Limited Sy No 153/1Gujarat | The sample does not conform to I.P. 2022 specification with respect to the content of ethylene glycol impurity, which is exceeding permissible limitOther | CDTL-HyderabadCDSCO lab |
| Sorbitol Solution 70% IP (Non-Crystallizing) | KA/018Mfg 2025-09 · Exp 2030-08 | Gujarat Ambuja Exports Limited Sy No 153/1Gujarat | The sample received does not conform to I.P. 2022 specification with respect to The content of ethylene glycol impurity, which is exceeding permissible limitOther | CDTL-HyderabadCDSCO lab |
| Sorbitol Solution 70% IP Non Crystallizing | 2526010Mfg 2025-05 · Exp 2030-04 | Gujarat Ambuja Exports Ltd. Plot No. A 04Gujarat | The sample does not conform to as Per IP in respect to The test for angle of Rotation.Other | CDTL, ChennaiCDSCO lab |
| Salbutamol Syrup IP | SVK 25040Mfg 2025-07 · Exp 2027-06 | Labinduss LtdKerala | Sample fails the test pH as per IP .pH | RDTL Ernakulam,KeralaState lab |
| Safe Hand Gloves | SHR0306Mfg 2021-06 · Exp 2026-07 | NM | SURGICAL GLOVESOther | DTL BaddiState lab |
| Ranitidine Oral Solution IP ZALTAC Syrup | MDL-C490Mfg 2025-08 · Exp 2027-07 | Marvellon Pharmaceuticals Pvt. Ltd. Kh. No. 114Himachal Pradesh | The sample does not conform to claim as per IP 2022 in respect to The test pH and Assay of Ranitidine Hydrochloride calculated as Ranitidine.Assay | RDTL, ChandigarhCDSCO lab |
| Rabeprazole Sodium and Domperidone Sustained Release Capsules RABILITE-DSR | B20824002Mfg 2024-02 · Exp 2026-01 | Torque Pharmaceuticals Pvt. Ltd 13B-14 | The sample does not conform to Manufacturers Specification with respect to The test of Dissolution of Rabeprazole Sodium (Acid Resistance in 0.1M HCl).Dissolution | CDL, KolkataCDSCO lab |
| Rabeprazole Sodium Injection IP | MD24G42Mfg 2024-07 · Exp 2026-06 | Martin &Brown Bio-Sciences Pvt. Ltd. K.No 918/419Himachal Pradesh | The sample does not conform to I.P. with respect to The tests of Description, Clarity of Solution, Particulate Matter, pH, Related Substances and Assay of Rabeprazole Sodium.Assay | CDL, KolkataCDSCO lab |
| Rabeprazole Sodium (EC) & Domperidone (SR) Capsules RABIVO-DSR | CG25-0039PMfg 2025-02 · Exp 2027-01 | Athens Life Sciences Mauza Rampur JattanHimachal Pradesh | The sample does not conform to claim with respect to The Assay of Rabeprazole Sodium.Assay | CDL, KolkataCDSCO lab |
| RYLES TUBE 12-FG (STERILE) | BRT-002Mfg 2024-07 · Exp 2026-06 | Bhagwati Medicare DevicesGujarat | The sample does not conform to claim as per Patent and Proprietary in respect to The Test of SterilitySterility | RDTL, ChandigarhCDSCO lab |
| Quinine Sulphate Tablets IP 300mg | TA25530Mfg 2025-06 · Exp 2027-05 | Saintlife Pharmaceuticals LtdUttarakhand | The sample does not conform to the IP with respect to in Dissolution.Dissolution | DTL JaipurState lab |
| Propoxur Sulphanilamide Cetrimide Powder | EE-240604Mfg 2024-06 · Exp 2026-05 | Ethicare Laboratories | The sample does no contorms to the claim with respect to Assay of PropoxurAssay | DTL UdaipurState lab |
| Progesterone Sustained Release Tablets 300 mg OPTOGEST 300 SR | T2B15001Mfg 2025-02 · Exp 2027-01 | Synokem Pharmaceuticals Ltd. No.56-57Uttarakhand | The sample does not conform to claim as per Manufacturer Specification with respect to test for Dissolution.Dissolution | CDL, KolkataCDSCO lab |
| Primaquine Phosphate Tablets IP 2.5 mg | T-1909Mfg 2024-06 · Exp 2026-05 | Jackson Laboratories Pvt. Ltd. Majitha RoadPunjab | The sample does not conform to claim as per I.P. 2022 with respect to The test for Assay and Dissolution of Primaquine.Assay | RDTL, GuwahatiCDSCO lab |
| Pregabaline & Nortriptyline Tablets (DGABA-N Tablets,) | VGT242301BMfg 2024-11 · Exp 2026-10 | Vrindavan Global Plot No. No. 23-BHimachal Pradesh | Misbranded.Misbranded | DCL TelanganaState lab |
| Prednisolone Tablets IP 20mg(Prednimeg-20) | ZRST-2403Mfg 2025-05 · Exp 2027-04 | ZRS Pharmaceuticals India Pvt. Ltd | Incorrect labellingLabelling | DTL, PuducherryState lab |
| Prednisolone Sodium Phosphate Drops Reslone (Drops 10ml) | L-250705Mfg 2025-07 · Exp 2027-06 | Dr. Pal'S Pharmaceuticals 10B-1Uttarakhand | The sample received does not conform with respect to The test for weight per ml.Weight | CDTL, MumbaiCDSCO lab |
| Polymeg 200, | INTK038722Mfg 2025-08 · Exp 2028-08 | Clariant IGL Specialty Chemicals Pvt. LtdUttarakhand | The sample received does not conform to U.S.P. specification with respect to The content of diethylene glycol impurity, which is exceeding permissible limitOther | CDTL-HyderabadCDSCO lab |
| Poly Ethylene Glycol - 200, | 43029642Mfg 2025-02 · Exp 2027-01 | Saudi Basic Industries Corporation (SABIC) | The sample received does not conform to U.S.P. specification with respect to The content of ethylene glycol and diethylene glycol impurities, which are exceeding permissible limitOther | CDTL-HyderabadCDSCO lab |
| Piperacillin and Tazobactam Injection I.P. 4.5 gm | 325-1088Mfg 2025-08 · Exp 2027-07 | Zee Laboratories Ltd. Behind 47Himachal Pradesh | The sample does not conform to claim as per IP 2022 in respect to The Test of Particulate matterParticulate matter | RDTL, ChandigarhCDSCO lab |
| Piperacillin and Tazobactam Injection I.P. 4.5 gm | 325-1090Mfg 2025-08 · Exp 2027-07 | Zee Laboratories Ltd.Behind 47Himachal Pradesh | The sample does not conform to claim as per IP 2022 in respect to The Test of Particulate matter.Particulate matter | RDTL, ChandigarhCDSCO lab |
| Phenylephrine Hydrochloride, Chlorpheniramine Maleate Qr-Cold Syrup | WDLB012Mfg 2025-06 · Exp 2027-05 | Westerlin Drugs Pvt. Ltd. Industrial Area Fatuha (Patna) - 803201Bihar | The sample does not conform to I.P. with respect to The Assay of Phenylephrine Hydrochloride.Assay | CDL, KolkataCDSCO lab |
| Phenylephrine Hydrochloride & Chlorpheniramine Maleate, Syrup IP(Ryminic Syrup) | BHCI284Mfg 2025-06 · Exp 2028-05 | Baseman Healthcare Inc | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Phenylephrine Hcl, Chlorpheniramine Maleate, Dextromethorphan Hbr Syrup (Pediacold DM ) | BHCI 276Mfg 2025-03 · Exp 2028-02 | Baseman Healthcare Inc | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate And Sodium Citrate Suspension((Ronikold - 250 Suspension)) | MMR-543Mfg 2024-08 · Exp 2026-07 | Mediguard Remedies | Failed Assay (for Phenylephrine Hydrochloride IP )Assay | DTL, PuducherryState lab |
| Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Drops SINUS DROPS | 876/26Mfg 2025-04 · Exp 2027-03 | Livin Formulations Survey No: 807 IDA Medchal Medchal-Malkajgiri DistrictTelangana | The sample received does not conform to manufacturer specification with respect to The test for pH only.pH | CDTL-HyderabadCDSCO lab |
| Paracetamol Tablets IP 650mg | PCT25057Mfg 2025-04 · Exp 2027-03 | Vivek Pharmachem (India) Ltd. NH-8Rajasthan | The sample received does not conform to as per IP in respect to The test for Dissolution.Dissolution | CDTL, ChennaiCDSCO lab |
| Paracetamol Tablets IP 650 mg Arvimol 650 Tablets | 24I-T1956EMfg 2024-12 · Exp 2026-11 | Orison Pharma International KhariHimachal Pradesh | The sample is not of standard quality for The reason stated under Description of The tablets.Description | RDTL, GuwahatiCDSCO lab |
| Paracetamol Tablets IP 500 mg | SKTC25002Mfg 2025-09 · Exp 2027-08 | Gidsha PharmaceuticalsGujarat | Assay of ofloxacinAssay | DTL BaddiState lab |
| Paracetamol Tablets IP 500 mg | PCT-2445Mfg 2024-10 · Exp 2027-03 | Suprex Laboratories | The sample does not comply as per I.P. 2022 with respect to The test for Dissolution of Paracetamol.Dissolution | RDTL, GuwahatiCDSCO lab |
| Paracetamol Tablet IP 500mg | PCT1203Mfg 2024-08 · Exp 2026-07 | Unicures India Ltd.C-21Uttar Pradesh | The sample does not conform to the I.P. with respect to Dissolution of Paracetamol.Dissolution | DTL JodhpurState lab |
| Pantoremed-40 Tables | AMT-0892AMfg 2024-10 · Exp 2026-09 | Avalon Medicines Pvt. Ltd. Plot No. 1271Haryana | The sample does not comply with IP requrements for Dissolution Test at Acid StageDissolution | FDAL, MumbaiState lab |
| Pantoprazole Gastro-Residtant Tablets IP 40 mg (Ptcid 40 Tablets) | BHA250196DMfg 2025-02 · Exp 2027-01 | Bionial Healthcare Pvt.LtdPunjab | Dissolution and DescriptionDissolution | DCL TelanganaState lab |
| Oral Rehydration Salts IP | OE50244Mfg 2025-09 · Exp 2027-02 | Caplet India Pvt.Ltd. RekjuaniWest Bengal | The sample does not conform to I.P. with respect to Uniformity of weight, Seal test and also for The reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Ondansetron and Ranitidine HCI Injection Vomibac R Injection | 110525Mfg 2025-05 · Exp 2027-04 | Pharma Chemico Laboratories DevghatHimachal Pradesh | The sample received does not conform to manufacturer specification with respect to The test for pH only.pH | CDTL-HyderabadCDSCO lab |
| Ondansetron Tablets IP Anset Tablets | RBMT-921Mfg 2025-09 · Exp 2028-08 | Ronald Pharmaceuticals (P) Ltd. B.No. 740-AGujarat | The sample does not conform to I.P. 2022 with respect to The test for Related substances.Related substances | CDTL, MumbaiCDSCO lab |
| Ondanserton orally disintergratin tablets IP 40mg (Ondifil Tabelts) | GT3C15Mfg 2024-03 · Exp 2026-02 | Ritual Drugs Pvt Ltd. Plot No. 271-272Haryana | The sample does not comply with IP requirement for Dissolution and Disintegration.Dissolution | FDAL, MumbaiState lab |
| Omeprazole Capsules 40 mg | JDC-1452Mfg 2024-10 · Exp 2026-09 | Jpee Drugs Plot No-53Uttarakhand | The sample does not conform to claim as per I.P. 2022 in respect to The Test of Dissolution (Acid Stage), Dissolution (Buffer Stage)Dissolution | CDL, KolkataCDSCO lab |
| Olmesartan Medoxomil Tablets IP 40 mg OLMESON-40 | T-6585Mfg 2025-07 · Exp 2027-07 | Jackson Laboratories Pvt.Ltd 22-24Punjab | The sample received does not conform to I.P. 2022, I.P. addendum 2024 specification with respect to The test for Dissolution only.Dissolution | CDTL-HyderabadCDSCO lab |
| Olmesartan Medoxomil Tablets IP 20mg | GT250287Mfg 2025-02 · Exp 2027-01 | Theon Pharmaceuticals LtdHimachal Pradesh | Sample fails the test Dissolution as per IP, as specified in the Laboratory ProtocolDissolution | DTL Thiruvananthapuram,KeralaState lab |
| Ofloxacin, Ornidazole(Hyflox-OZ) | OZ004-24Mfg 2024-04 · Exp 2026-03 | Harihar Pharmaceuticals Pvt. Ltd. SBP Road | Dissolution testDissolution | SDT&RL, BhubaneswarState lab |
| Ofloxacin Tablets I.P. 400 mg | OFB-506Mfg 2023-03 · Exp 2026-02 | Healers Lab Unit-IIHimachal Pradesh | Dissolution testDissolution | SDT&RL, BhubaneswarState lab |
| New unsyn Tablets Acetyl Salicyclic Acid BP 150mg Paracetamol BP 150mg, Caffeine (Anhydrous) BP 25mg Tablets | 63Mfg 2023-08 · Exp 2026-07 | National Pharmacetutical G-18/1Maharashtra | DescriptionDescription | FDAL, MumbaiState lab |
| Neosorb 70/70B-Sirop De Sorbitol (Sorbitol Liquid, Crystallising USP/NF) | 599646Mfg 2023-03 · Exp 2028-03 | Roquette Freres | The sample received does not conform to as per IP in respect to The test for angle of Rotation only.Other | CDTL, ChennaiCDSCO lab |
| My Young Model Foundation | 6Mfg 2025-04 · Exp 2028-03 | Sidhi Vinayak CoDelhi | Test For Suspended SolidsOther | Government of NCT of DelhiState lab |
| Montelukast Sodium & Levocetirizine Hydrochloride Dispersible Tablets, (CIVIKAST-LC KID) | GT240841Mfg 2024-04 · Exp 2026-03 | Theon Pharmaceuticals LtdHimachal Pradesh | The sample does not conform to Schedule V of Drugs Rules 1940 with respect to the test Disintegration as per IPDisintegration | DTL Thrissur,KeralaState lab |
| Metoprolol Succinate Prolonged Release Tablets IP Metloc ER50 | MER3 294DMfg 2024-11 · Exp 2026-10 | Pulse Pharmaceuticals Pvt. Ltd. Khasra No. 400Uttarakhand | The sample is not of standard quality for The reasons stated under DescriptionDescription | CDTL -IndoreCDSCO lab |
| Methycoblamin Oral Disintegrating Tablets 1500 mcg (MecoNeuron OD) | MOD1085DMfg 2025-07 · Exp 2027-06 | Pulse Pharmaceuticals Pvt LtdUttarakhand | Description and Uniformity of DispersionDescription | SDTL, PunjabState lab |
| Metformin Hydrochloride Prolonged Release & Glimepiride Tablets IP,(Ajapride M2) | NHD24148AMfg 2024-03 · Exp 2027-02 | Nest Healthcare Pvt.LtdGujarat | Sample fails the test Descriptive Part for the tablets as per IP.Other | DTL Thiruvananthapuram,KeralaState lab |
| Menadione Sodium Bisulphite Injection IP Kaytin MB 1ml | MA25D33Mfg 2025-04 · Exp 2027-03 | Martin & Brown Bio-Sciences Pvt. Ltd. K.No 918/419Himachal Pradesh | The sample received does not conform to The I.P. with respect to The test for Assay of Menadione Sodium BisulphiteAssay | CDTL, MumbaiCDSCO lab |
| Luliitech Cream | DF200Mfg 2024-04 · Exp 2026-03 | Hygieia Home And Personal Care Solution Khasra No. 437 | Assay and MisbrandedAssay | FDAL, MumbaiState lab |
| Luliconazole Lotion IP 1% W/V LUZORAN Lotion 30ml | R09GE2518BMfg 2025-09 · Exp 2027-08 | Rednex Pharmaceuticals Limited Survey No : 586 & 231Kerala | The sample received does not conform to I.P. 2022 with respect to The test for Related substance.Related substances | CDTL, MumbaiCDSCO lab |
| Lorazepam Injection IP 2 mg/ml, 2 ml WELOR | WALV24001AMfg 2024-10 · Exp 2026-03 | Welcure Remedies Nahan RoadHimachal Pradesh | The sample does not conform to I.P. with respect to test for Particulate matter, Assay and is also not of standard quality for The reason stated under Description.Assay | CDL, KolkataCDSCO lab |
| Loratadine Ambroxol HCI, Guaiphenesin and Menthol Syrup | REN027Mfg 2024-11 · Exp 2026-10 | Enicar Pharmaceutical Pvt. Ltd. J-214Maharashtra | The sample does not conform to the claim witm respect to Assay of Menthol and colourAssay | DTL, JaipurState lab |
| Levosalbutamol, Guaiphenesin And Ambroxol Syrup(BRETHNOL EXPECTORANT) | BEL 6003Mfg 2024-12 · Exp 2026-11 | Bangalore Antibiotics and Biologicals Pvt LtdKarnataka | pHpH | DTL, PuducherryState lab |
| Levosalbutamol, Ambroxol Hydrochloride & Guaiphenesin Syrup (Ambroflex-LS Syrup ) | AFG-2502Mfg 2025-05 · Exp 2027-04 | Apple Formulations Pvt LtdUttarakhand | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Levosalbutamol, Ambroxol Hydrochloride & Guaiphenesin Syrup STUQOF-LS | TS-538Mfg 2025-07 · Exp 2027-06 | Trimedix Pharma (P) Ltd. C-40Punjab | The sample does not conform to claim as per Patent and Proprietary in respect to The Assay of Levosalbutamol Sulphate calculated as LevosalbutamolAssay | RDTL, ChandigarhCDSCO lab |
| Levosalbutamol, Ambroxol Hydrochloride & Guaiphenesin Syrup AMBROX-LG | TS-249Mfg 2025-04 · Exp 2027-03 | Trimedix Pharma (P) Ltd. C-40Punjab | The sample does not conform to claim as per Patent and Proprietary in respect to The Assay of Levosalbutamol Sulphate calculated as LevosalbutamolAssay | RDTL, ChandigarhCDSCO lab |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride and Guaiphenesin Syrup(Cafact-LS ) | EPL-043Mfg 2025-09 · Exp 2027-08 | Elixia Pharmaceuticals | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride & Guaiphenesin Syrup(Coffix-LS ) | ASL25019Mfg 2025-04 · Exp 2027-03 | Res SanctaHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride & Guaiphenesin Syrup(Broxin-SB Expectorant) | LA5029AMfg 2025-01 · Exp 2026-12 | Navkar LifesciencesHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride & Guaiphenesin Syrup(Brolin Syrup) | ECL/24/904Mfg 2025-03 · Exp 2027-02 | Emmchak Formulations Pvt. Ltd | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Levocetirizine Hydrochloride and Montelukast Sodium Tablets IP | TA250025Mfg 2025-01 · Exp 2026-12 | Orchid Medlife Pvt. LtdHimachal Pradesh | Dissolution (Montelukast Sodium)Dissolution | SDTL, GuwahatiState lab |
| Levocetirizine Hydrochloride & Montelukast Sodium Tablets IP (Alticet-M) | UGT-24842BMfg 2024-08 · Exp 2026-07 | Ultra Drugs Pvt. LtdHimachal Pradesh | Failed Description (Spots)Description | DTL, PuducherryState lab |
| Levocetirizine Hydrochloride & Montelukast Sodium Suspension(LEMONT KID) | VS2538Mfg 2025-10 · Exp 2027-09 | Vertex Pharma ChemicalsPuducherry | Failed Description and assay (For Levocetirizine hydrochloride) & Incorrect LabellingAssay | DTL, PuducherryState lab |
| Levocetirizine & Montelukast Tablets IP | TGT25-156Mfg 2025-07 · Exp 2027-06 | Athens Life Sciences Mauza Rampur JattanHimachal Pradesh | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua Jammu and KashmirState lab |
| Levocetirizine Tablets IP 5mg Levocet | GT23624CMfg 2023-07 · Exp 2026-06 | Hetero Healthcare Ltd. Alldc Industrial Growth Centre ChangsariAssam | DescriptionDescription | FDAL, MumbaiState lab |
| Levocetirizine Dihydrochloride & Montelukast Sodium Tablets IP | LT-25029Mfg 2025-09 · Exp 2027-08 | YL PharmaHimachal Pradesh | The sample does not HP conform to the IP with respect to Assay.Assay | DTL, JaipurState lab |
| Levocetirizine Dihydrochloride & Montelukast Tablets 11 | TR25C042CMfg 2025-03 · Exp 2027-02 | Rhombus Pharma Pvt. Ltd. Survey No. 807/002Gujarat | The sample does not conmorm to the IP with respect to Assay of Lexncetirizine Dihydrochloride & MoptelukasAssay | DTL JodhpurState lab |
| Levocetirizine Dihydrochloride Tablets | YLT25023Mfg 2025-03 · Exp 2027-02 | YL PharmaHimachal Pradesh | The sample does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab |
| Levetiracetam Tablets IP 500 mg Epivell-500 Tablets | GT5F136Mfg 2025-06 · Exp 2027-05 | Ritual Drugs Pvt. Ltd. (A WHO-GMP Certified Company) Plot No. 271-272Haryana | The sample received does not conform to I.P. 2022 specification with respect to The test for Dissolution only.Dissolution | CDTL-HyderabadCDSCO lab |
| Levetiracetam Tablets IP 500 mg | LTH2505Mfg 2025-09 · Exp 2027-08 | Applied Communication & ControlsUttarakhand | The sample does not conform to claim as per IP 2022 in respect to The Test of Dissolution.Dissolution | RDTL, ChandigarhCDSCO lab |
| LEVTARY - 500 | AA250585AMfg 2025-07 · Exp 2027-06 | Gufic Biosciences Limited N.H.No. 08 KabilporeGujarat | The sample does not conform to claim as per Patent and Proprietary in respect to The Test of Free drugOther | RDTL, ChandigarhCDSCO lab |
| Itraconazole Capsules BP 200 mg | R08GC2506AMfg 2025-08 · Exp 2027-07 | Rednex Pharmaceuticals Ltd. Survey No : 586 & 231Kerala | The sample received does not conform to I.P. 2022 with respect to The test for Dissolution.Dissolution | CDTL, MumbaiCDSCO lab |
| Iodine Tincture IP 66 | IT251Mfg 2025-08 · Exp 2027-07 | Apex Healthcare | AssayAssay | DTL, JaipurState lab |
| Ibuprofen and Paracetamol Suspension SNEFLAM DS SUSPENSION, 60 ml | L25J001Mfg 2025-10 · Exp 2027-09 | Snehal Pharma & Surgicals Pvt. Ltd. B-1/11Maharashtra | The sample does not conform to claim with respect to The test for Microbial contamination (Test of Total Aerobic Viable Count)Microbial limits | CDTL, MumbaiCDSCO lab |
| ITRAZIL-200 | HA237Mfg 2025-02 · Exp 2027-01 | Trio Lifescience Private LtdGujarat | The sample received does not conform to The manufacture's specification with respect to The test for pH.pH | CDTL, MumbaiCDSCO lab |
| Hydroxyzine Oral Solution I.P. | HO1LF002Mfg 2025-06 · Exp 2027-05 | Unicure India Ltd. Plot No. 46(B)/49BUttarakhand | The sample does not conform to claim as per IP 2022 in respect to The test of Related SubstanceRelated substances | CDL, KolkataCDSCO lab |
| Hydroxychloroquine Sulphate Tablets IP 200mg (Auto Q-200) | 308225004Mfg 2025-07 · Exp 2027-06 | Regenix Drugs Ltd | Uniformity of weightUniformity of weight/content | Drugs Testing Laboratory, Madurai -19State lab |
| Glycerin IP | 3F/RG/24/0054Mfg 2024-11 · Exp 2029-10 | 3F Industries Ltd. 1604Andhra Pradesh | The sample received does not conform to I.P. 2022 with respect to The test for Aldehydes.Other | CDTL, MumbaiCDSCO lab |
| Glipizide and Metformin Tablets USP | URDT0328Mfg 2023-01 · Exp 2025-12 | Unicure India LtdUttarakhand | The sample does not conform to the IP with respect to Dissolution of Glipizide.Dissolution | DTL UdaipurState lab |
| Gentamicin Injection IP 2ml | 683508Mfg 2025-05 · Exp 2027-04 | Zazen Pharma Pvt Ltd | pHpH | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab |
| Expecotrant, Bronchodilator, Mucolytic(Spair ) | LPA-5071Mfg 2025-07 · Exp 2027-06 | Spinka PharmaTelangana | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Eucalyptus Oil IP | 654Mfg 2025-10 · Exp 2027-09 | Repacked by Ganesh Eucalyptus Oil Disitillery | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Esomeprazole (EC) & Itopride Hydrochloride Capsule | PGC25-08Mfg 2025-03 · Exp 2027-02 | Plena Remedies | The sample does not conforms to the claim with respect to Assay of EsomeprazoleAssay | DTL, UdaipurState lab |
| Enteric Coated Rabeprazole Sodium & Domperidone Sustained release Capsules Rabizole - DSR | SPK 1386Mfg 2024-11 · Exp 2026-10 | Spanker Biotech Ltd. Vill. Makhanu MajraHimachal Pradesh | The sample does not conform to Manufacturers Specification with respect to The Test of Dissolution of Rabeprazole Sodium and Assay of Rabeprazole Sodium.Assay | CDL, KolkataCDSCO lab |
| Drotaverine HCl Suspension PED-DS suspension 60ml | L-250901Mfg 2025-09 · Exp 2030-08 | Dr. Pal's Pharmaceuticals 10B-1Uttarakhand | The sample does not conform to claim with respect to The test for Microbial contamination (Total Aerobic Viable Count and Total Fungal Count).Microbial limits | CDTL, MumbaiCDSCO lab |
| Diclofenac Sodium, Paracetamol & Chlorzoxazone Tablets Diclotrum-MR | SGT-231863Mfg 2024-01 · Exp 2025-12 | Spectrum Formulation Pvt. Ltd. Khasra No.12Uttarakhand | The sample does not conform to claim with respect to Description.Description | CDL, KolkataCDSCO lab |
| Diclofenac Potassium Tablets USP(Ark-75 Tablets ) | AST-24002Mfg 2024-06 · Exp 2027-05 | Apex Laboratories private ltdTamil Nadu | Misbranded.Misbranded | DCL TelanganaState lab |
| Diclofenac Potassium & Pracetamol Tablets | PCGT-25013Mfg 2025-01 · Exp 2026-12 | Pentachem PharmaceuticalsHimachal Pradesh | The sample does not conform to the claim with respect to AssayAssay | DTL, JaipurState lab |
| Diclofenac Potassium & Paracetamol Tablets (MUSCARE-P TAB.) | YLT25027Mfg 2025-07 · Exp 2027-06 | YL PharmaHimachal Pradesh | Diclofeanc Potassium Assay 83.54% & Assay Of Paracetamol 79.83%Assay | DTL BADDIState lab |
| Diclofenac Gastro-resistant Tablets I.P. 50 mg | 25T19052Mfg 2025-02 · Exp 2027-01 | Kras Pharmaceuticals Pvt. LtdBihar | The sample does not conform to IP with respect to test for Dissolution in Buffer Stage.Dissolution | CDL, KolkataCDSCO lab |
| Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup (Yokurex D Syrup) | L250320Mfg 2025-03 · Exp 2027-02 | SGS Formulation Pvt. LtdTamil Nadu | Failed Assay (for Phenylephrine Hydrochloride IP )Assay | DTL, PuducherryState lab |
| Dextromethorphan Hydrobromide, Chlorpheniramine Maleate, Phenylephrine Hydrochloride Syrup(Caredex Junior ) | CXR-2502Mfg 2025-06 · Exp 2027-05 | Apple Formulations Pvt. LtdUttarakhand | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Dextromethorphan Hydrobromide, Ambroxol Hydrochloride, Chlorpheniramine Maleate, Phenylephrine Hydrochloride & Menthol Syrup (RespiFresh-AD Cough and Cold Formula) | CLAD4016Mfg 2024-12 · Exp 2026-11 | Crest Lifescoences Pvt. LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Dextromethorphan Hydrobromide, Ambroxol Hydrochloride, Chlorpheniramine Maleate, Phenylephrine Hydrochloride & Menthol Syrup (RespiFresh-AD ) | CLAD4017Mfg 2024-12 · Exp 2026-11 | Crest Lifescoences Pvt. LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Dextromethorphan Hydrobromide, Ambroxol Hydrochloride, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Syrup Tusty Total | OLM24120Mfg 2024-12 · Exp 2030-08 | Medishri Healthcare Pvt. Ltd. Khasra No.-27Uttarakhand | The sample received does not conform to manufacturer specification with respect to The test for Assay of ambroxol hydrochloride content only.Assay | CDTL-HyderabadCDSCO lab |
| Dextromethorphan HBr, Phenylephrine HCI & CPM Syrup(Koff-Max D) | LLD-8030Mfg 2024-05 · Exp 2026-04 | Lifevision HealthcareHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Dextromethorphan HBR, Phenylephrine Hydrochloride, & Chlorpheniramine Maleate Syrup (Dexril syrup) | MMR-872Mfg 2025-03 · Exp 2027-02 | Mediguard Remedies | Failed Assay (for Phenylephrine Hydrochloride IP )Assay | DTL, PuducherryState lab |
| Dexamethasone Tablets BP 8 mg. Dexarid-8 | RT230508Mfg 2023-07 · Exp 2026-06 | Ridley Life Science Pvt. Ltd D-1651Delhi | The sample does not conform to claim as per B.P. 2025 with respect to The test for Assay of Dexamethasone.Assay | RDTL, GuwahatiCDSCO lab |
| Dexamethasone Sodium Phosphate Injection IP 4 mg/ml. DEXOHIN | 69Mfg 2025-06 · Exp 2027-05 | Hindustan Medicines Pvt. Ltd. Barauni-851112 BiharBihar | The sample does not conform to IP with respect to test for Particulate matter and is also not of standard quality for The reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Cyproheptadine, Tricholine and Sorbitol oral solution Cypliv | L25078Mfg 2025-08 · Exp 2027-07 | Wamika Pharmaceuticals Private LimitedHaryana | The sample does not conform to claim as per Patent and Proprietary in respect to The Assay of Sorbitol (70%).Assay | RDTL, ChandigarhCDSCO lab |
| Cotton Bandage | 940Mfg 2025-05 · Exp 2027-04 | Sapna Bunkar Hath Kargha Sahkari Samiti LtdRajasthan | The sample does not conform in respect to The Test of Threads per dm, Weight In Gm/sq.m, Foreign Matter, Fluorescence.Weight | CDL, KolkataCDSCO lab |
| Cotton Bandage | 937Mfg 2025-05 · Exp 2027-04 | Sapna Bunkar Hath Kargha Sahkari Samiti LtdRajasthan | The sample does not conform to The test of weight in Gm/sq.m, threads per dm, Fluorescence, Foreign MatterWeight | CDL, KolkataCDSCO lab |
| Clopidogrel & Aspirin Tablets IP | GT250518Mfg 2025-03 · Exp 2027-02 | Theon Pharmaceuticals Ltd. Vill. Saini MajraHimachal Pradesh | The sample Received Does Not Conform To I.P. 2022 Specification With Respect To The Description And Test For Free Salicylic Acid Only.Description | CDTL-HyderabadCDSCO lab |
| Clopidogrel & Aspirin Tablets IP | GT250519Mfg 2025-03 · Exp 2027-02 | Theon Pharmaceuticals Ltd. Vill. Saini MajraHimachal Pradesh | The sample Received Does Not Conform To I.P. 2022 Specification With Respect To The Description And Test For Free Salicylic Acid Only.Description | CDTL-HyderabadCDSCO lab |
| Ciprofloxacin Tablets IP 500mg | 2140Mfg 2023-01 · Exp 2025-12 | Hindustan Antibiotics LtdMaharashtra | Failed Description (Rough Surface)Description | DTL, PuducherryState lab |
| Chlorpheniramine Maleate, Dextromethorphan Hydrobromide & Phenylephrine Hydrochloride Syrup(Cofcross Syrup) | LSC-25171Mfg 2025-02 · Exp 2027-01 | Prochem Pharmaceuticals Pvt. LtdUttarakhand | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Chlorpheniramine Maleate & Phenylephrine Hcl Syrup I.P. Ezicold Syrup 60ml | L3126Mfg 2025-09 · Exp 2027-08 | Camper Healthcare Plot No. C-01Gujarat | The sample received does not conform to I.P. 2022 with respect to The test of Assay of Phenylephrine Hydrochloride.Assay | CDTL, MumbaiCDSCO lab |
| Ceftriaxone & Sulbactam for Injection IP (Keftragard-1500) | KPD034021AQMfg 2024-07 · Exp 2026-06 | Ipca Laboratories Unit- II C-6 Sara Ind. Estate Chakrata Road Rampur Dehradun 248197 (Uttarakhand)Uttarakhand | MisbrandedMisbranded | SDTL Raipur ChhattisgarhState lab |
| Cefpodoxime Proxetil Dispersible Tablets 200 mg (Cefonsa-200 DT Tablets) | MVT-749Mfg 2024-09 · Exp 2026-08 | Bonn Schtering Bio SciencesPuducherry | Dissolution and Misbranded.Dissolution | DCL TelanganaState lab |
| Cefixime & Lactic Acid Bacillus Tablets Medisefix - 200 LB | DBT138AMfg 2023-10 · Exp 2026-09 | Digital Vision 176Himachal Pradesh | The sample does not conform to claim with respect to The Assay of Cefixim and Lactic Acid Bacillus.Assay | CDL, KolkataCDSCO lab |
| Cefixime & Azithromycin, Lactic Acid Bacillus Tablets(ARRCEF- AZ ) | 2827Mfg 2025-05 · Exp 2027-04 | MLARRX Pharmaceuticals No 18 Gopalakrishanan Raod T Nagar Chennai 600017Tamil Nadu | AssayAssay | SDTL Raipur ChhattisgarhState lab |
| Cefixime & Azithromycin with Lactic Acid Bacillus Tablets (G-CEF- AZ ) | GB-2440Mfg 2024-11 · Exp 2026-10 | MG - Biotech Pvt. LtdHimachal Pradesh | AssayAssay | SDTL Raipur ChhattisgarhState lab |
| Calcium and Vitamin D3 Tablets IP | BCB01AAAMfg 2025-01 · Exp 2026-12 | Akums Drugs & Pharmaceuticals Ltd. At. Plot NO. 26A | The sample does not conform to the IP with respect to Assay Vitamin D3Assay | DTL, JaipurState lab |
| Calcium Carbonate & Vitamin D3 Tablets (Nemical) | SBT-2179Mfg 2025-04 · Exp 2026-09 | Sterlife Biotech Pvt.LtdGujarat | Sample does not conform to IP with respect to Dissolution and Assay of Vitamin D3Assay | DTL Thrissur,KeralaState lab |
| Calcium & Vitamin D3 Tablets IP (500 mg/250IU) | CDA-583Mfg 2025-03 · Exp 2027-02 | Healers Lab Unit-IIHimachal Pradesh | The sample does not comply as per I.P. 2022 with respect to The test for Dissolution of Calcium.Dissolution | RDTL, GuwahatiCDSCO lab |
| Bromhexine Hydrochloride,Terbutaline Sulphate,Guaiphenesin & Menthol Syrup Respifresh-TR | R12GL2426Mfg 2024-12 · Exp 2026-11 | Rednex Pharmaceuticals Limited Survey No : 586 & 231Kerala | The sample does not conform to claim as per Schedule V, Drugs & Cosmetics Act in respect to The Assay of Menthol.Assay | CDL, KolkataCDSCO lab |
| Basm Multi-Spectrum Expectorant | MBM 18Mfg 2025-09 · Exp 2027-08 | Medline Pharmaceuticals Pvt LtdTamil Nadu | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Atorvastatin Tablets IP 20mg | CT24250048Mfg 2024-04 · Exp 2026-03 | CMG Biotech Pvt. Ltd. Unit-II | Assay and Dissolution testAssay | SDT&RL, BhubaneswarState lab |
| Atorvastatin Tablets IP 10mg (Atorwal-10) | IC434002Mfg 2024-02 · Exp 2026-01 | Innova Captab Ltd. 81-B EPIPHimachal Pradesh | Assay & Dissolution testAssay | SDT&RL, BhubaneswarState lab |
| Amoxycillin Potassium Clavulanate & Lactic Acid Bacillus Tablets IP | GCA012Mfg 2025-04 · Exp 2027-03 | GC Healthcare Vill Lower Ambota Sec.- 6 Parwanoo Dist.- Solan (H.P.)Himachal Pradesh | AssayAssay | SDTL Raipur ChhattisgarhState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP(CLAVAM 625) | 25441325Mfg 2025-04 · Exp 2026-09 | Alkem Health ScienceSikkim | The sample does not conform to standard quality in respect of the test for Dissolution of Amoxycillin performed.Dissolution | SDTL, Govt. of Tripura, Agartala. State- TripuraState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP(Amoxheal ? 625 ) | ACAA24149CMfg 2025-01 · Exp 2026-06 | J.M. LaboratoriesHimachal Pradesh | The sample does not conform to standard quality in respect of the test for Dissolution & Assay of Amoxycillin performed.Assay | SDTL, Govt. of Tripura, Agartala. State- TripuraState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP (500mg+125mg), (Symbiotik XL-625) | SH255011Mfg 2025-05 · Exp 2027-04 | Sotac Healthcare Private LimitedGujarat | Sample fails the tests Dissolution for Amoxycillin and Clavulanic Acid and Assay of Clavulanic Acid.Assay | RDTL Ernakulam,KeralaState lab |
| Amoxycilin, Clavulanic Acid (Kaiclav-625 LB) | ABT24350Mfg 2024-10 · Exp 2026-03 | Alexa PharmaceuticalsHimachal Pradesh | Content of Amoxycillin and Clavulanic acidOther | SDT&RL, BhubaneswarState lab |
| Amlodipine Tablets I.P. 2.5 mg | 424-1522Mfg 2024-08 · Exp 2026-07 | Zee Laboratories 47Himachal Pradesh | The sample is not of standard quality for The reason stated under Description of The tablets.Description | RDTL, GuwahatiCDSCO lab |
| Amlodipine Besylate and Atenolol Tablets(Amlobact AT ) | ABAT-035Mfg 2024-11 · Exp 2027-04 | IOSIS Remedies Pvt LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Amitriptyline Hydrochloride Tablets IP 25mg | ATJ-06Mfg 2023-11 · Exp 2026-10 | Argon Remedies Pvt LtdUttarakhand | Failed Description (Capping & Cracking)Description | DTL, PuducherryState lab |
| Amikacin Sulphate Injection I.P. Mikabenz 500 | SVI-24070Mfg 2024-05 · Exp 2026-04 | Sunvet HealthcareHimachal Pradesh | The sample does not conform to I.P. with respect to test for Particulate matter and is also not of standard quality for The reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Amikacin Injection IP 100 mg | LI25292Mfg 2025-09 · Exp 2027-08 | Agron Remedies Pvt. Ltd. SarverkheraUttarakhand | The sample does not conform to I.P. with respect to test for Particulate matter and is also not of standard quality for The reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Ambroxol,Terbutaline,Guaiphenesin and Menthol syrup AMBROLET-LS | OS-12095Mfg 2025-09 · Exp 2027-08 | Omnison Pharma Pvt. Ltd. G-456 | The sample does not conform to claim as per Patent and Proprietary in respect to The Test of Total yeast and mould count.Other | RDTL, ChandigarhCDSCO lab |
| Ambroxol Hydrochloride. Levosalbutamol Sulphate and Guaiphenesin syrup (Brokuff LS Junior Syrup ) | BKJ-2503Mfg 2025-04 · Exp 2027-03 | Apple Formulations Pvt. LtdUttarakhand | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Ambroxol Hydrochloride, Terbutnline Sulphate, Guaiphensesin & Menthol Syrup | BS25061Mfg 2025-06 · Exp 2027-05 | B.Sharda LifescienceGujarat | The sample does not conform to the Claim with respect to Assay Ambroxol Hdyrochloride Menthol and DEG.Assay | DTL, JaipurState lab |
| Ambroxol Hydrochloride, Terbutalline Sulphate, Guaiphenesin & Menthol Syrup(soltus TS) | BL-14Mfg 2025-06 · Exp 2027-05 | Boffin Biotech Pvt .LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup Wamicof-AX Expectorant | L25082Mfg 2025-09 · Exp 2027-08 | Wamika Pharmaceuticals Private LimitedHaryana | The sample does not conform to claim as per Patent and Proprietary in respect to The Assay of Terbutaline SulphateAssay | RDTL, ChandigarhCDSCO lab |
| Ambroxol Hydrochloride, Guaiphenesin and Levosalbutamol Syrup Corun-LA Junior Syrup | A20497BMfg 2025-03 · Exp 2027-02 | Aspen Lifesciences Plot No. 57Punjab | The sample does not conform to claim as per Manufacturer's Specification with respect to Assay of Ambroxol Hydrochloride.Assay | CDL, KolkataCDSCO lab |
| Ambroxol Hydrochloride I.P-15.0mg Terbutaline Sulphate I.P-1.25mg Guaiphenesin I.P 50.0mg Menthol I.P -2.5mg GBS JUNIOR | 25L06Mfg 2025-02 · Exp 2028-01 | Oro Pharmaceuticals Pvt LtdOdisha | The sample does not conform to claim with respect to Assay of Menthol.Assay | CDL, KolkataCDSCO lab |
| Ambroxol HCI, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup(Coftant Syrup) | AMS25D258Mfg 2025-08 · Exp 2027-07 | Alop Medi-Sciences Pvt. LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Albendazole Tablets IP 400mg | 370725001Mfg 2025-08 · Exp 2028-07 | Ravenbhel Healthcare Pvt.LtdJammu & Kashmir | Sample fails the test Dissolution as specified in the Laboratory Protocol as per IP.Dissolution | DTL Thiruvananthapuram,KeralaState lab |
| Albendazole Tablets IP 400 mg | AAO-2502Mfg 2025-04 · Exp 2027-03 | Apple Formulations Pvt. Ltd. Plot No. 208Uttarakhand | Assay (Albendazole)Assay | SDTL, GuwahatiState lab |
| Albendazole Tablets IP 400 mg | MT250971Mfg 2025-10 · Exp 2027-09 | Mancare Laboratories Pvt. LtdUttarakhand | DissolutionDissolution | SDTL Raipur ChhattisgarhState lab |
| Albendazole Tablets IP 400 mg | MT250990Mfg 2025-10 · Exp 2027-09 | Mancare Laboratories Pvt. LtdUttarakhand | DissolutionDissolution | SDTL Raipur ChhattisgarhState lab |
| Albendazole Tablets IP 400 mg | MT250998Mfg 2025-10 · Exp 2027-09 | Mancare Laboratories Pvt. LtdUttarakhand | DissolutionDissolution | SDTL Raipur ChhattisgarhState lab |
| Albendazole Tablets IP 400 mg | MT250987Mfg 2025-10 · Exp 2027-09 | Mancare Laboratories Pvt. LtdUttarakhand | DissolutionDissolution | SDTL Raipur ChhattisgarhState lab |
| Albendazole Tablets IP 400 mg | MT250981Mfg 2025-10 · Exp 2027-09 | Mancare Laboratories Pvt. LtdUttarakhand | DissolutionDissolution | SDTL Raipur ChhattisgarhState lab |
| Albendazole Tablets IP 400 mg | MT250989Mfg 2025-10 · Exp 2027-09 | Mancare Laboratories Pvt. LtdUttarakhand | DissolutionDissolution | SDTL Raipur ChhattisgarhState lab |
| Albendazole Tablets IP 400 mg | MT251010Mfg 2025-10 · Exp 2027-09 | Mancare Laboratories Pvt. LtdUttarakhand | DissolutionDissolution | SDTL Raipur ChhattisgarhState lab |
| Albendazole Tablet IP | PGT24347Mfg 2024-06 · Exp 2027-05 | Affy Parenterals Vill. GullarwalaHimachal Pradesh | The sample does not conform to claim as per IP 2022 in respect to The Test of DissolutionDissolution | RDTL, ChandigarhCDSCO lab |
| Albendazole Oral Suspension IP ALBEND | LBS-006/25Mfg 2025-10 · Exp 2028-09 | Drakt InternationalWest Bengal | The sample does not conform to I.P. with respect to The Assay of Albendazole.Assay | CDL, KolkataCDSCO lab |
| Agtha-LS Cough Syrup | UF2674717HMfg 2024-09 · Exp 2026-08 | Ultra Drugs Formulations Pvt LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Aceclofenac, Paracetamol & Serratiopeptidase Tablets Getwalk-SP) | SSPT-01929Mfg 2024-06 · Exp 2027-05 | Savya Pharmaceuticals | The sample does not conform to the claim with respect to Assay of Aceclofenac.Assay | DTL, JaipurState lab |
| Aceclofenac Tablets IP 100mg | M25800001Mfg 2025-04 · Exp 2027-03 | Dr.Miltons Laboratories Private LimitedPuducherry | Break up of TabletsOther | Drugs Testing Laboratory, Chennai-06State lab |
| Aceclofenac & Paracetamol Tablets(Editrak Tablets ) | GVP2504Mfg 2025-09 · Exp 2027-08 | Glatrix biotech Pvt.LtdTelangana | Misbranded.Misbranded | DCL TelanganaState lab |
| Aceclofenac & Paracetamol Tablets (Floxy-P) | GT-10033Mfg 2025-09 · Exp 2027-08 | Gag Pharmaceuticals | Dissolution and MisbrandedDissolution | SDTL, PunjabState lab |
| Aceclofenac & Paracetamol Tablets | 0069Mfg 2024-10 · Exp 2026-09 | Hindustan Antibiotics Ltd PimpriMaharashtra | Failed Assay (for Aceclofenac IP ) & Incorrect labellingAssay | DTL, PuducherryState lab |
| Aceclofena? Paracetamol & Serratiopeptidase Tablets | RT2506062Mfg 2025-06 · Exp 2027-05 | Shri Ramesh Industry Pvt LtdHimachal Pradesh | The sample does not conform to the claim with respect to in Assay.Assay | DTL, JaipurState lab |
| (Levosalbutamol Sulphate, Ambroxol Hydrochloride and Guaiphenesin Syrup)(Cafact-LS ) | EPL-009Mfg 2025-02 · Exp 2027-01 | Elixia pharmaceuticals | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| (Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Syrup)(Respolite-D) | SR 080Mfg 2024-12 · Exp 2026-11 | Sresan Pharmaceutical ManufacturerKarnataka | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| (Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Syrup)(Medcof Cough Syrup) | GE 127Mfg 2025-08 · Exp 2027-07 | Acmey Inc | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| (Acebrophylline, Terbutaline Sulphate & Guaiphenesin Syrup) (Sputnix -AB ) | AMS25D051Mfg 2025-02 · Exp 2027-01 | Alop Medi-Sciences Pvt. LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
Suspected spurious batches in this alert
| Product | Batch | Labelled manufacturer | Reported by | Firm's reply |
|---|---|---|---|---|
| (CHYMORAL FORTE) Trypsin-Chymotrypsin Tablets | 2KU6L012 | Under Investigation | Food & Drugs Laboratory, Vadodara | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| (Montina-L Tablets) Montelukast Sodium and Levocetirizine Hydrochloride Tablets IP | SPJ241236 | Under Investigation | RDTL,Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets Zerodol-SP | FND072001BH | Ipca Laboratories Ltd. 393/394, Melli Jorethang Road, Gom Block, Bharikhola, South District, Sikkim 737 121 | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets ZERODOL-SP TABLETS | FND0725001BH | Ipca Laboratories Ltd. 393/394, Melli Jorethang Road, Gom Block, Bharikhola, South District, Sikkim 737 121 | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Telma-AM Telmisartan 40 mg and Amlodipine 5 mg Tablets IP | 05241038A | Under Investigation | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Telma 40 Telmisartan Tablets I.P. 40 mg | 18240413 | Under Investigation | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Telma-AM Telmisartan 40mg and Amlodipine 5 mg Tablets IP | 18240626 | Under Investigation | FDAL, Mumbai | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Deflazacort Tablets 6 mg Defcort 6 | 13240334A | Macleods Pharmaceuticals Ltd. 367/7, Kabra Industrial Estate, Kachigam, Daman 396 210 (U.T.) | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Chymoral Forte Trypsin-Chymotrypsin Tablets | 2KU6L045 | Under Investigation | FDAL, Mumbai | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| (Pantop-D SR) Pantoprazole Sodium Gastro-resistant and Domperidone Prolonged -release Capsules IP | SPA250021 | Under Investigation | RDTL,Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
Check your medicine. Enter the batch number printed on the strip, bottle or carton to see whether it appears in this or any earlier alert. Check a batch number
Official sources and primary records
- Regulator
- Regulator
Changelog
- 20 Sep 2026: table generated from the CDSCO NSQ portal export (175 rows). Revised CDSCO lists are diffed on each monthly rebuild.